Continuing cost pressures will force pharmaceutical companies to transform, with a focus on leveraging digital business models within the healthcare ecosystem.

Peter Behner

EY Global Health Sciences and Wellness Strategy and Transactions Leader

Transformation leader in the development of new strategic direction for life sciences companies. Family focused. Loves fast cars, good wines and history books.

Peter has had a successful career as a strategy consultant in the Life Science industry over the past 25 years. He has worked for several tier one strategy firms in the US and Europe. With extensive industry experience in pharma, biotech and medical diagnostics, he is a widely recognized authority in the industry on commercial trade channel management. 

Peter holds a combined BE and ME (Dipl. Ing.) from RWTH-Aachen in mechanical engineering. Fluent in German, English and French.

How Peter is building a better working world

“In my work, I am helping clients to make sure their drugs and devices are available at the right time and place when needed by patients. I am currently helping an increasing number of clients develop and bring to market better and more efficacious drugs by leveraging the new possibilities that the digital ecosystem provides.”

Peter's latest thinking

    Contact Peter